Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Advancing Molecular Therapies to First Line in BRAF-Mutated mCRC: Insights From Emerging Data
Description:
Host: Scott Kopetz, MD, PhD
Host: Cathy Eng, MD, FACP
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.